Literature DB >> 6307429

Alpha-thalassemia is related to prolonged survival in sickle cell anemia.

J G Mears, H M Lachman, D Labie, R L Nagel.   

Abstract

We have determined the frequency of deletional alpha-thalassemia in black populations in the USA and Africa that harbor sickle cell anemia. In normals, the frequency of the chromosome bearing a deletion of one of the two normal alpha gene loci, designated (-alpha), ranged from 0.12 to 0.16, and in sickle trait subjects, the frequency ranged from 0.18 to 0.20. By contrast, in sickle cell anemia subjects, the frequency was significantly greater and ranged from 0.22 to 0.33. Analysis demonstrated that the greater frequency in the last group was primarily a result of an increased number of subjects with alpha-thalassemia trait (also called homozygous alpha-thalassemia-2). In addition, the frequency of the (-alpha) chromosome was found to increase progressively with age, supporting the hypothesis that alpha-thalassemia is favorable to the survival of subjects with sickle cell anemia. Thus, individuals who inherit alpha-thalassemia and sickle cell anemia may represent a subgroup of patients with a longer life expectancy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307429

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Analysis of crossover type in the alpha -3.7 haplotype among sickle cell anemia patients from various parts of Africa.

Authors:  C Dodé; A Berth; J Rochette; R Girot; D Labie
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

2.  alpha-Thalassemia among sickle cell anemia patients in various African populations.

Authors:  J Pagnier; O Dunda-Belkhodja; I Zohoun; J Teyssier; H Baya; G Jaeger; R L Nagel; D Labie
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.

Authors:  S H Embury; M R Clark; G Monroy; N Mohandas
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

Review 4.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

5.  Alpha thalassemia among sickle cell anaemia patients in Kampala, Uganda.

Authors:  Irene Lubega; Christopher M Ndugwa; Edison A Mworozi; James K Tumwine
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

6.  Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea.

Authors:  Françoise Bernaudin; Cécile Arnaud; Annie Kamdem; Isabelle Hau; Françoise Lelong; Ralph Epaud; Corinne Pondarré; Serge Pissard
Journal:  Blood Adv       Date:  2018-03-27

7.  Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease.

Authors:  James G Taylor; Diana Ackah; Crystal Cobb; Nick Orr; Melanie J Percy; Vandana Sachdev; Roberto Machado; Oswaldo Castro; Gregory J Kato; Stephen J Chanock; Mark T Gladwin
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

8.  Longitudinal Analysis of Patient Specific Predictors for Mortality in Sickle Cell Disease.

Authors:  Susanna A Curtis; Neeraja Danda; Zipora Etzion; Hillel W Cohen; Henny H Billett
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

9.  Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth.

Authors:  Graham R Serjeant; Nicki Chin; Monika R Asnani; Beryl E Serjeant; Karlene P Mason; Ian R Hambleton; Jennifer M Knight-Madden
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

10.  Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing.

Authors:  Adekunle Adekile; Nagihan Akbulut-Jeradi; Rasha Al Khaldi; Maria Jinky Fernandez; Jalaja Sukumaran
Journal:  J Pers Med       Date:  2021-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.